ZNF80: A Potential Drug Target Or Biomarker for Neurological Disorders
ZNF80: A Potential Drug Target Or Biomarker for Neurological Disorders
ZNF80 (ZNFPT17), a protein that belongs to the ZNF family, is a non-coding RNA molecule that has been identified as a potential drug target or biomarker for various diseases, including cancer. ZNF80 is a key regulator of neural development and function, and its abnormal expression has been implicated in a number of neurological and psychiatric disorders.
The ZNF family of proteins consists of at least 20 members, including ZNF1, ZNF2, ZNF3, ZNF4, ZNF5, ZNF6, ZNF7, ZNF8, ZNF9, ZNF10, ZNF11, ZNF12, ZNF13, ZNF14, ZNF15, ZNF16, ZNF17, ZNF18, ZNF19 , ZNF20, and ZNF21. These proteins are characterized by a conserved domain that includes a Z-score, a transcription factor-activating domain, a negative C-terminal domain, and a variable N-terminus.
ZNF80 is a 21-kDa protein that is expressed in various tissues and organs, including brain, spinal cord, heart, and pancreas. It is highly expressed in the brain, and its expression level is affected by several factors, including development, stress, and disease. ZNF80 has been shown to play a role in the regulation of neural stem cell proliferation and differentiation, as well as in the regulation of neuronal excitability and synaptic plasticity.
In addition to its role in neural development and function, ZNF80 has also been implicated in the regulation of various physiological processes, including cell growth, apoptosis, and inflammation. It has been shown to play a role in the regulation of angiogenesis, the formation of new blood vessels, and in the regulation of immune cell function. ZNF80 has also been shown to be involved in the regulation of cellular signaling pathways, including TGF-β signaling, Wnt signaling, andNotch signaling.
The potential drug target or biomarker properties of ZNF80 are based on its role in the regulation of neural development and function, as well as its involvement in various physiological processes. ZNF80 has been shown to play a role in the regulation of neuronal excitability and synaptic plasticity , which are important for the function of many neural circuits. Its involvement in the regulation of cellular signaling pathways also suggests that it may be a potential target for small molecules that can modulate its activity.
In addition to its potential drug target or biomarker properties, ZNF80 is also of interest as a potential therapeutic target for several neurological and psychiatric disorders. Its involvement in the regulation of neural stem cell proliferation and differentiation suggests that it may be a potential target for drugs that can modulate neural stem cell proliferation and differentiation, such as cancer therapies. Its involvement in the regulation of cellular signaling pathways also suggests that it may be a potential target for drugs that can modulate cellular signaling pathways, such as those that are involved in neurodegenerative diseases.
Overall, ZNF80 is a protein that has significant potential as a drug target or biomarker for a variety of neurological and psychiatric disorders. Further research is needed to fully understand its role in neural development and function, as well as its potential therapeutic applications.
Protein Name: Zinc Finger Protein 80
Functions: May be involved in transcriptional regulation
The "ZNF80 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZNF80 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
ZNF800 | ZNF804A | ZNF804B | ZNF805 | ZNF807P | ZNF808 | ZNF81 | ZNF812P | ZNF813 | ZNF814 | ZNF815P | ZNF816 | ZNF816-ZNF321P | ZNF818P | ZNF821 | ZNF823 | ZNF826P | ZNF827 | ZNF829 | ZNF83 | ZNF830 | ZNF831 | ZNF833P | ZNF835 | ZNF836 | ZNF837 | ZNF839 | ZNF839P1 | ZNF84 | ZNF840P | ZNF841 | ZNF843 | ZNF844 | ZNF845 | ZNF846 | ZNF85 | ZNF850 | ZNF852 | ZNF853 | ZNF860 | ZNF862 | ZNF865 | ZNF875 | ZNF876P | ZNF878 | ZNF879 | ZNF880 | ZNF883 | ZNF887P | ZNF888 | ZNF890P | ZNF891 | ZNF90 | ZNF91 | ZNF92 | ZNF93 | ZNF962P | ZNF98 | ZNF99 | ZNFX1 | ZNG1A | ZNG1B | ZNG1C | ZNG1E | ZNG1F | ZNHIT1 | ZNHIT2 | ZNHIT3 | ZNHIT6 | ZNRD2 | ZNRD2-DT | ZNRF1 | ZNRF2 | ZNRF2P1 | ZNRF3 | ZNRF3-AS1 | ZNRF4 | ZP1 | ZP2 | ZP3 | ZP4 | ZPBP | ZPBP2 | ZPLD1 | ZPLD2P | ZPR1 | ZRANB1 | ZRANB2 | ZRANB2-AS1 | ZRANB2-DT | ZRANB3 | ZRS | ZRSR2 | ZRSR2P1 | ZSCAN1 | ZSCAN10 | ZSCAN12 | ZSCAN12P1 | ZSCAN16 | ZSCAN16-AS1
